Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) appoints Camilla Lönn as CFO
Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) has appointed Camilla Lönn as the company’s new CFO.
Camilla Lönn holds a degree in accounting from Uppsala University. She has extensive experience in roles in finance, accounting, and as a CFO, both as a consultant and as an employee. Camilla's recent roles have focused on smaller publicly traded companies, including assignments within the healthcare sector. Most recently, Camilla served as interim CFO for the First North listed company Brilliant Future AB.
Erik Hedlund, Chairman of the Board and main owner of Perpetua Medical, comments: "Camilla's broad experience and competence in accounting and controlling from publicly traded companies, combined with her experience in driving change and integration work, will make her a key person at Perpetua Medical."
Erik Hedlund continues: "I also want to take this opportunity to thank Liselotte Söder, who has chosen to take on new challenges outside the company. Liselotte has loyally contributed her solid expertise during a time when the original operations faced significant challenges. I wish her all the best in her future endeavors."
This is a translation from the Swedish version of the press release. If any subject of interpretation between the two, the Swedish version prevails.
For more information contact:
Erik Hedlund, Chairman
Email: erik.hedlund@nolsterbyinvest.se
Phone: +46 70-382 08 41
About Perpetua Medical AB
Perpetua Medical AB (publ), formerly Pharmacolog i Uppsala AB, is a company active in the healthcare sector and with headquarter in Uppsala, Sweden. The company's shares (ticker PERP B) are traded on Nasdaq First North Stockholm.
The following trademarks are owned and protected by Perpetua Medical AB: Pharmacolog™-logo, WasteLog™and Pharmacolog Dashboard™.
Further information regarding the company is available at https://pharmacolog.com/.
The company's Certified Adviser is Mangold Fondkommission AB.
Tags:
